Publisher
Springer International Publishing
Reference6 articles.
1. Liberman JA, Cooper TB, Suckow RF, Steinberg H, Borenstein M, Brenner R, Kane JM. Tricyclic antidepressant and metabolite levels in chronic renal failure. Clin Pharmacol Ther. 1985;37(3):301–7.
2. Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo J, Leonard P, Valaer C. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. Pharm Ther. 2014;39(6):427–35.
3. Capel MM, Jenkins R, Jefferson M, Thomas DM. Use of ketamine for ischemic pain in end-stage renal failure. J Pain Symptom Manage. 2008;35:232–4.
4. De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis. Clin Pharmacol Ther. 2006;80(6):597–606.
5. Pham PC, Khaing K, Sieveres TM, Pham PM, Miller JM, Pham SV, Pham PA, Pham PT. 2017 Update on pain management in patients with chronic kidney disease. Clin Kidney J. 2017;10(5):688–97.